Simplex Trading
MRKR icon

Simplex Trading’s Marker Therapeutics MRKR Stock Holding History

Simplex Trading’s Portfolio MRKR Stock Details MRKR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-380
Closed -$1K – 10669
2022
Q1 		$1K Sell
380
-100
-21% -$571 ﹤0.01% 10108
2021
Q4 		$4K Sell
480
-1,910
-80% -$25.4K ﹤0.01% 9689
2021
Q3 		$68K Hold
2,390
– – ﹤0.01% 7125
2021
Q2 		$66K Buy
2,390
+2,355
+6,729% +$62K ﹤0.01% 7290
2021
Q1 		$77K Buy
+35
New +$801 ﹤0.01% 6102
2020
Q3 		– Sell
-2
Closed -$3K – 8204
2020
Q2 		$3K Sell
2
-3
-60% -$66 ﹤0.01% 7160
2020
Q1 		$9K Sell
5
-4
-44% -$102 ﹤0.01% 6540
2019
Q4 		$27K Sell
9
-40
-82% -$1.46K ﹤0.01% 5732
2019
Q3 		$249K Buy
49
+41
+513% +$2.42K ﹤0.01% 3344
2019
Q2 		$64K Buy
+8
New +$475 ﹤0.01% 4641

Other funds holding MRKR

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AAM
AR Asset Management West Hollywood, California $517M AUM 18.31% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
MAA
Matrix Asset Advisors White Plains, New York $1.23B AUM 26.4% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Simplex Trading's MRKR Position: Q1 2023 in Review

Simplex Trading sold out of Marker Therapeutics (MRKR) in Q1 2023, closing a stake of 16 shares.

Simplex Trading first reported a position in MRKR in Q1 2019 and held it in 12 quarters. The position peaked at $183K in Q1 2021. 30 funds tracked by Wall St. Rank hold MRKR as of Q1 2023.

  • Simplex Trading reported no remaining Marker Therapeutics position as of Q1 2023 after selling out during the quarter.
  • Simplex Trading sold 16 Marker Therapeutics shares in Q1 2023.
  • Simplex Trading first reported a position in Marker Therapeutics in Q1 2019 and held it in 12 quarters.
  • Simplex Trading's Marker Therapeutics position peaked at $183K in Q1 2021.
  • 30 funds tracked by Wall St. Rank held Marker Therapeutics as of Q1 2023.

Based on Simplex Trading's 13F filing for Q1 2023, filed 27 Apr 2023.